Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Study to Evaluate the Safety and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell Infusion in Frailty Patients

NCT07449364 is registered in ClinicalTrials.gov with Daewoong Group Indonesia as lead sponsor.

NCT NCT07449364
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07449364 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Study to Evaluate the Safety and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell Infusion in Frailty Patients
Lead sponsor
Daewoong Group Indonesia
Phase
Not applicable
Overall status
Completed
Start date
March 24, 2025
Completion date
December 5, 2025
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

frailty in older adults